Atlas Trials

Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)

Clinical trial NCT07204977 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07204977
Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Amyotrophic Lateral SclerosisMotor Neuron Disease
Start date
2026-02-02
Primary completion
2027-09-30
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.